ABSTRACT
The voluntary and unpaid blood donation is recommended by all international authorities (WHO, Council of Europe, ISBT, EBA), because it represents the best way of aiming towards self-sufficiency in blood products of all kinds, while preserving an optimal level of quality and safety for recipients as for donors. Still infrequent in many developing countries it tends to develop. However, the objective assigned by the WHO to reach 100% of unpaid and voluntary blood donations in 2020 appears ambitious, in particular for the collection of plasma intended to the splitting industry. The close evaluation of European directives concerning the donation of human body elements should allow harmonization of practices by Member States.
Subject(s)
Blood Donors , Blood Transfusion , Volunteers , Altruism , Blood Donors/psychology , Blood Donors/statistics & numerical data , Blood Safety , Blood Transfusion/psychology , European Union , Humans , Motivation , Volunteers/psychologyABSTRACT
The not-for-profit issue has been debated in November 2016 in Paris; this issue is one of the four canonical pillars of ethical blood donation. It is intimately bound to benevolence though it is distinct, as not-for-profit calls for institutions while benevolence calls for individuals. It is indeed intended that voluntary blood donors do not benefit from their donation and are thus non-remunerated. Not-for-profit is essential since it refers to the public character of blood as a putative public resource aimed at being shared as a tribute of solidarity. A central question however is linked to the capacity- or not -of public sectors to ensure that blood components are universally available, with special mention to plasma derived drugs, without the contribution of the for profit, private sector.
Subject(s)
Beneficence , Blood Donors/ethics , Blood Transfusion/ethics , Academies and Institutes , France , Humans , MotivationABSTRACT
Voluntariness stands for one of the four pillars of ethics in blood donation; it is, however, more related to tradition than to legislation. Because it seems necessary to apply "marketing" techniques to blood collection in order to meet the needs in blood components, both in terms of quantity and quality, one wonders if this may be at the expense of this principle of voluntariness. This seminar-belonging actually to a series of seminars in Ethics in Transfusion Medicine-aimed at questioning the possible weakness of voluntariness in the field of blood donation. To achieve this goal, specialists of numerous disciplines in medical sciences, law and humanities gathered to discuss all related issues to voluntariness in blood donation.
Subject(s)
Blood Donors/ethics , Transfusion Medicine/ethics , Volunteers , Altruism , Attitude to Health , Blood Donors/legislation & jurisprudence , Blood Donors/psychology , Blood Safety , Blood Transfusion/economics , Blood Transfusion/ethics , Blood Transfusion/legislation & jurisprudence , Health Services Needs and Demand , Humans , Motivation , Persuasive Communication , Power, Psychological , Remuneration , Social ValuesABSTRACT
The current issues debate brings together experts around the themes of self-sufficiency (in its national and European aspects) and of needs in cellular blood products. The point of view of the manufacturer and prescribers of blood products are confronted.
Subject(s)
Blood Safety , Blood Banks , Blood Donors/supply & distribution , Blood Safety/standards , Blood Transfusion/statistics & numerical data , France , Health Services Needs and Demand , Humans , Prescriptions/statistics & numerical dataABSTRACT
This paper brings together the abstracts and proceedings of a seminar held on the topic of "ethics and transfusion", October 15, 2013 at the National Institute of Blood Transfusion, Paris.
Subject(s)
Blood Donors/ethics , Blood Transfusion/ethics , Ethics, Medical , Congresses as Topic , HumansABSTRACT
The current issues debate will bring together experts around the themes of self-sufficiency (in its national and European aspects) and of needs in cellular blood products. The point of view of the manufacturer and prescribers of blood products will be confronted.